Quick Takeaways
- Ronil A. Patel has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $296,181.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Ronil A. Patel
- Location
- Farmington Hills, MI
- Summary
- The estimated net worth of Ronil A. Patel is at least $296,181 dollars as of 12 Jan 2024. Ronil A. Patel is the Chief Business Officer of Ocuphire Pharma, Inc. and owns shares of Opus Genetics, Inc. (IRD) stock worth about $296.2K.
- Signature
- /s/ Stephanie Swan, by Power of Attorney
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Ronil A. Patel and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Ocuphire Pharma, Inc. ($296,181).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Ronil A. Patel
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| IRD | Ocuphire Pharma, Inc. | Chief Business Officer | $296,181 | 10 Jan 2024 |
Insider Transactions Reported by Ronil A. Patel:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.